methyl (1S,15R,16S,20S)-16-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

Ajmalicine; LC-ESI-ITFT; MS2; CE: 10%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 100%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 105%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 20%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 25%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 55%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 65%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 85%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+

Ajmalicine; LC-ESI-ITFT; MS2; CE: 95%; R=15000; [M+H]+

Ajmalicine; LC-ESI-QTOF; MS2; [M+H]+; CE: 10eV

Ajmalicine; LC-ESI-QTOF; MS2; [M+H]+; CE: 20eV

Ajmalicine; LC-ESI-QTOF; MS2; [M+H]+; CE: 30eV

Ajmalicine; LC-ESI-QTOF; MS2; [M+H]+; CE: 40eV

Ajmalicine; LC-ESI-QTOF; MS2; [M+H]+; CE: 50eV